Mark Gallivan

1.3k total citations
14 papers, 339 citations indexed

About

Mark Gallivan is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Gallivan has authored 14 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Infectious Diseases and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Gallivan's work include Retinal Imaging and Analysis (3 papers), COVID-19 epidemiological studies (3 papers) and Infectious Diseases and Tuberculosis (3 papers). Mark Gallivan is often cited by papers focused on Retinal Imaging and Analysis (3 papers), COVID-19 epidemiological studies (3 papers) and Infectious Diseases and Tuberculosis (3 papers). Mark Gallivan collaborates with scholars based in United States, Switzerland and France. Mark Gallivan's co-authors include Ben Oppenheim, Nita Madhav, Nathan Wolfe, Patrick Ayscue, Neha Shah, Prime Mulembakani, Edward M. Rubin, Jennifer Flood, Theodore Leng and Charles Li and has published in prestigious journals such as PLoS ONE, Ophthalmology and Emerging infectious diseases.

In The Last Decade

Mark Gallivan

14 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Gallivan United States	7	118	92	69	62	56	14	339
Lyndon P. James United States	8	61 0.5×	51 0.6×	65 0.9×	39 0.6×	35 0.6×	17	304
Sarah Osman United States	5	168 1.4×	151 1.6×	71 1.0×	44 0.7×	91 1.6×	9	437
Yi-Chun Wu Taiwan	9	145 1.2×	100 1.1×	31 0.4×	44 0.7×	39 0.7×	12	303
Richard Schabas Canada	11	113 1.0×	70 0.8×	20 0.3×	104 1.7×	31 0.6×	19	356
Hasiya Yusuf United States	10	158 1.3×	51 0.6×	30 0.4×	75 1.2×	27 0.5×	32	316
Samuel K. Ayeh United States	9	160 1.4×	66 0.7×	35 0.5×	52 0.8×	17 0.3×	14	333
Abbas Omaar Switzerland	3	125 1.1×	128 1.4×	74 1.1×	20 0.3×	52 0.9×	5	392
Mathias Dzobo South Africa	11	173 1.5×	158 1.7×	99 1.4×	60 1.0×	76 1.4×	31	579
Simone Villa Italy	11	320 2.7×	57 0.6×	52 0.8×	117 1.9×	30 0.5×	31	535
Hashim Talib Hashim Iraq	10	72 0.6×	49 0.5×	22 0.3×	34 0.5×	64 1.1×	97	340

Countries citing papers authored by Mark Gallivan

Since Specialization

Citations

This map shows the geographic impact of Mark Gallivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gallivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gallivan more than expected).

Fields of papers citing papers by Mark Gallivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gallivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gallivan. The network helps show where Mark Gallivan may publish in the future.

Co-authorship network of co-authors of Mark Gallivan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Gallivan. A scholar is included among the top collaborators of Mark Gallivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Gallivan. Mark Gallivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Gallivan, Mark, et al.. (2023). Emulating VIEW 1 and VIEW 2 Clinical Trial Outcome Data Using the American Academy of Ophthalmology IRIS Registry. Ophthalmic surgery, lasers & imaging retina. 54(1). 6–14. 4 indexed citations

Leng, Theodore, Jason J. Schwartz, Mark Gallivan, et al.. (2022). Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry. Ophthalmology and Therapy. 12(1). 325–340. 7 indexed citations

Leng, Theodore, Mark Gallivan, Ashley Kras, et al.. (2021). Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes: An IRIS® Registry Study. Ophthalmology. 128(12). 1782–1784. 16 indexed citations

Gallivan, Mark, Ben Oppenheim, & Nita Madhav. (2019). Using social media to estimate Zika's impact on tourism: #babymoon, 2014-2017. PLoS ONE. 14(2). e0212507–e0212507. 10 indexed citations

Oppenheim, Ben, et al.. (2019). Assessing global preparedness for the next pandemic: development and application of an Epidemic Preparedness Index. BMJ Global Health. 4(1). e001157–e001157. 146 indexed citations

Madhav, Nita, Ben Oppenheim, Mark Gallivan, et al.. (2017). Pandemics: Risks, Impacts, and Mitigation. Europe PMC (PubMed Central). 91 indexed citations

Gallivan, Mark, et al.. (2016). Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail. Open Forum Infectious Diseases. 3(1). ofv220–ofv220. 16 indexed citations

Gallivan, Mark, Neha Shah, & Jennifer Flood. (2015). Epidemiology of HumanMycobacterium bovisDisease, California, USA, 2003–2011. Emerging infectious diseases. 21(3). 435–443. 37 indexed citations

Gallivan, Mark, Erin L. Murray, & Kathleen Harriman. (2015). Association of Streptococcus pneumoniae Meningitis After Head Injury or Brain Surgery—California, 2013–2014. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations

10.

Gallivan, Mark, Kathryn H. Lofy, & Gary Goldbaum. (2013). Use of Death Certificates to Identify Tuberculosis-Related Deaths in Washington State. Journal of Public Health Management and Practice. 23(2). e12–e15. 3 indexed citations

11.

Gallivan, Mark. (1987). Inpatient use declines: persistent but slower.. PubMed. 61(3). 34, 36–34, 36. 1 indexed citations

12.

Gallivan, Mark. (1986). Technology planning: an imperative, not an option.. PubMed. 60(2). 100–100. 1 indexed citations

13.

Gallivan, Mark. (1986). Self-insurance wave continues.. PubMed. 60(2). 34–34. 1 indexed citations

14.

Gallivan, Mark. (1985). Physician offices invade clinical laboratory market.. PubMed. 59(20). 84, 89, 92–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact